IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans.
about
Current therapies for lowering lipoprotein (a)Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentrationLipoprotein (a): impact by ethnicity and environmental and medical conditionsNovel multiple sclerosis susceptibility loci implicated in epigenetic regulationDistinct metabolic network states manifest in the gene expression profiles of pediatric inflammatory bowel disease patients and controlsComparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease riskGenome-wide association study of biologically informed periodontal complex traits offers novel insights into the genetic basis of periodontal diseaseCoenzyme Q10 Status as a Determinant of Muscular Strength in Two Independent Cohorts.New and emerging biomarkers in cardiovascular disease.The PF4/PPBP/CXCL5 Gene Cluster Is Associated with Periodontitis.Structure, function, and genetics of lipoprotein (a).Beneficial Effects of a Dietary Weight Loss Intervention on Human Gut Microbiome Diversity and Metabolism Are Not Sustained during Weight Maintenance.Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota.Lipoprotein(a): A Lipoprotein Whose Time Has Come.Lipoprotein(a): A missing culprit in the management of athero-thrombosis?A haplotype block downstream of plasminogen is associated with chronic and aggressive periodontitis.A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis.Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.Genome-wide association study of serum coenzyme Q10 levels identifies susceptibility loci linked to neuronal diseases.Determination of the coenzyme Q10 status in a large Caucasian study population.Elevated Lp(a) and Abdominal Aortic Aneurysm.Integration of Murine and Human Studies for Mapping Periodontitis Susceptibility.DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.Genome-wide association meta-analysis of coronary artery disease and periodontitis reveals a novel shared risk locus
P2860
Q26830297-BECB6162-7BE6-4A06-9C58-DEE903189FA3Q36897158-482B0493-80BA-4991-BC6E-726FC02F7EB0Q37033161-E7ABF9CE-13CC-4A7C-820C-293CCF1B31DDQ37056269-757B6AB7-1D86-46DE-B1FA-E6D8859A6FF0Q37227773-21CE0897-1BE6-4CB5-98F6-9984E263DD36Q37282484-FE7DCD5D-2F55-4C69-8D74-DB671D286718Q37334501-D408A683-C818-4490-9A68-A6A3A3EB9742Q37336133-DBE1F2C2-40C0-48B1-A58B-35031B3DB62BQ37462442-18D34263-B98E-4C78-ABFC-F2B56EDE2906Q38586900-C555BA0D-EDAA-4329-AEB0-5016C6605AE6Q38806943-C66F0A82-50ED-4BB1-A295-B6A62C4AE15FQ38807488-E7764440-C2EA-4BAE-BD39-9E99328E13F6Q39145500-FEB9B370-9DE9-4B84-B5CA-340AB815ADB8Q39305621-1588500C-9DC2-4A35-B361-A8F02FC4C208Q39308941-653D1162-D085-4B2E-9AF9-3ECB94C1AFA4Q39368804-307BDF87-6751-4130-B2F4-FC39874DAFD0Q40184177-30AD1605-E4E9-4800-84F7-93DADD8EB23AQ40225148-70C3AEE3-05F9-4A07-96E9-5523996C516CQ40469545-4BA2BBAC-3E70-4C92-A222-7E32AD14E38DQ40767246-48EFC37F-7AF9-4C66-8EF6-2BF49F1C6937Q41528932-3F197EAE-D601-4799-B2A7-D7122D89D150Q45932677-92823B29-BDE0-4EFF-BD59-C09220C0E7ABQ47222417-D5E6805E-7BC1-4FB8-A37B-A1D4AD5A9271Q55401408-68F8E6D2-D641-472A-AD79-A146C0D0AF71Q57418298-BA6062A5-3E4A-4900-8960-D5C6D559ABE8
P2860
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
IL-6 blockade by monoclonal an ...... otein (a) synthesis in humans.
@ast
IL-6 blockade by monoclonal an ...... otein (a) synthesis in humans.
@en
type
label
IL-6 blockade by monoclonal an ...... otein (a) synthesis in humans.
@ast
IL-6 blockade by monoclonal an ...... otein (a) synthesis in humans.
@en
prefLabel
IL-6 blockade by monoclonal an ...... otein (a) synthesis in humans.
@ast
IL-6 blockade by monoclonal an ...... otein (a) synthesis in humans.
@en
P2093
P2860
P50
P356
P1476
IL-6 blockade by monoclonal an ...... otein (a) synthesis in humans.
@en
P2093
Dominik M Schulte
Ioanna Gouni-Berthold
Johann O Schröder
Kathrin Türk
Matthias Laudes
Nike Müller
Rainald Zeuner
Sandra Freitag-Wolf
Stefan Schreiber
Wilhelm Krone
P2860
P304
P356
10.1194/JLR.P052209
P577
2015-02-21T00:00:00Z